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1. Introduction
With the increasing rate of musculoskeletal
pathologies affecting the world population
due to ever-higher life expectancy and the
aging population, the development of
better treatment strategies for tackling
bone-related disorders is of great impor-
tance. Bone tissue engineering (BTE)
presents an important and promising alter-
native to conventional approaches such as
the use of autografts, considered the
current gold standard treatment.[1] The
use of top-down techniques is the most
typical and allows for the use of a wide
range of materials and good control over
the scaffolds’ physical properties.[2]
Furthermore, to be an efficient tool, a
scaffold should be biocompatible, nontoxic,
provide structural support for cell
attachment, and support in vivo develop-
ment of extracellular matrix (ECM) in dam-
aged tissue. The bone’s ECM possesses
hierarchical organization and plays an
important role in fracture repair.[3] It is
mainly composed of collagen type I and II, elastin, fibronectin,
laminins, proteoglycans, glycosaminoglycans, and growth
factors bond to the ECM proteins to be released according to
the physiological needs of the cell.[4] Among the scaffolds
developed, biomimetic hierarchical scaffolds have sparked the
development of improved BTE approaches.[5,6] Mimicking the
native tissue in its hierarchical structure, chemical composition,
and properties is the ultimate goal of regenerative scaffold
designing. In BTE, the strife for ever more biomimetic scaffold
systems has led to use biomotifs in scaffold design, attempting to
recreate bone matrix structure and composition.[7] There are sev-
eral different approaches and targets for biomimicry. Striving
towardmimicking the natural bone tissue in respect to both com-
plex 3D structure and composition is a step forward in biomate-
rial research but also toward developing patient-specific
therapeutics.[8,9]
In recent years, several BTE approaches have been developed
that resulted in scaffold systems that more closely mimic the nat-
ural tissue.[10] Several different strategies can be used to mimic
specific aspects and properties of bone and its ECM. The mim-
icking of specific structural, mechanical, and biological cues of
the ECM that can facilitate host cell differentiation and prolifera-
tion is achievable using BTE approaches.[11]
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The increasing rate of musculoskeletal pathologies has compelled the develop-
ment of improved and novel treatment strategies in order to address unmet
clinical needs. Tissue engineering approaches comprising the use of scaffolds for
bone regeneration have been showing to be a promising alternative to conven-
tional bone repair/substitution approaches. In particular, hierarchical scaffolds as
methods of structural support and osteogenic differentiation promoters are
among the most used tools in bone tissue engineering (BTE). In this reasoning,
hierarchical scaffolds have sparked the field, striving towardmimicking the natural
bone tissue in both, its complex 3D structure and composition. A recent and
promising trend has been the merging of nanotechnology and tissue engineering
concepts. As such the incorporation of nanoparticles and nanocomposites into
micro- or macroscaffold systems can result in an improvement of scaffolds’
biofunctionality at different levels. These tools are versatile in nature and can be
used for multiple purposes such as drug delivery, thermal conductors, and
mechanical reinforcement. Taking into consideration multidisciplinary
approaches, several strategies have been pursued. The recent reports dealing with
the approaches pursued in the hierarchical scaffolds production and enhance-
ment, ranging from the nanoscale to the macroscale, are overviewed herein.
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The design of hierarchical scaffolds heavily relies on the spe-
cific properties of the featured biomaterial. The recent materials
of interest and top-down approaches pursued by hierarchical
scaffolds’ production and enhancement, ranging from the nano-
scale to the macroscale (Figure 1), are overviewed herein.
2. Macrometric Approaches
BTE heavily relies on the development of scaffolds for effective
bone defect reparation. The vast majority of the submacrometric
approaches complement or enhance developed scaffolds.
Scaffolds play a crucial role in BTE by providing a 3D environ-
ment for cell adhesion and proliferation.[12] Several biomaterials
have proven to be excellent base materials for hierarchical scaf-
fold production as depicted in Table 1.
Among these, natural and synthetic polymers, bioceramic
scaffolds, and decellularized ECM (dECM) approaches have
gained increasing interest in recent years (Figure 2).
2.1. Natural and Synthetic Polymers
Natural polymers as base materials for bone scaffolds possess the
advantage of ensuring bioactivity, a biomimetic surface, and pro-
viding optimal cell attachment and growth. Yet, immunogenic
response, poor mechanical properties, and low tunability repre-
sent challenges for their application.[13,14] Among the most stud-
ied natural polymers for scaffolds’ production are collagen, silk
fibroin (SF), alginate, chitosan, and hyaluronic acid.
Collagen is the main component of the ECM of bone tissue
and a natural choice for BTE scaffolds. Collagen is one of the
most used biomaterials for scaffold production because it serves
as a template for mineralization and it is enzymatically biode-
gradable. Collagen type I is the most used for engineering appli-
cations because it is part of the natural ECM and thus eliminating
immunological reactivity.[15,16] For example, Yu et al.[17] used
intrafibrillar mineralized collagen hydroxyapatite (HAp) as its
building blocks to obtain biomimetic scaffolds produced by a
one-step biomineralization process with the help of synthetic
analogues of noncollagenous proteins. These scaffolds closely
resemble bone in both structure and composition. In this study,
Fe and Mn were incorporated in the lamellar scaffold which led
to a further improvement of the osteogenic potential of the sys-
tem. In vitro studies performed with bone marrow-derived mesen-
chymal stem cells (BMSCs) showed increased osteogenic-specific
gene expression and alkaline phosphatase (ALP) activity as well as
enhanced cell adhesion and osteoblast proliferation. Additionally,
an in vivo assay performed on fresh bone marrow cells showed
superior bone regeneration capability of the system.[17]
In the case of SF, its unique mechanical properties make it a
versatile tool for multiple applications. In the case of scaffolds’
production, this biopolymer presents specific advantages in both
versatility and mechanical strength. SF porosity can be controlled
through ice-templating allowing the production of anisotropic or
hierarchical structures.[18] Moreover, it can be used in a vast array
of applications, such as load-bearing scaffolds or sutures, taking
advantage of the SF flexibility and high tensile strength.[19] Also,
its mechanical strength is superior when compared to other bio-
degradable polymers, like collagen or chitosan, and its proteolytic
degradation presents an advantage when compared to synthetic
polymers.[20] The usefulness of these characteristics can be seen
in the application of Liu et al.[21] who developed a biomimetic
porous SF/biphasic calcium phosphate (BCP) scaffold, using
phase separation method and freeze-drying, with improved
mechanical properties. The addition of SF improved scaffolds’
mechanical properties when compared to pure BCP scaffolds
and the incorporation of SF showed to be better for cell growth
of preosteoblasts cells. This system that can effectively mimic the
natural bone matrix displayed excellent osteogenic capacity in a
rat model, as evidenced by the rapid proliferation of seeded osteo-
blasts and ALP activity. Furthermore, the formation of an apatite
layer can occur through the exchange of calcium and phospho-
rous between BCP and body fluids providing osteoblast with the
raw materials to secrete bone matrix.[21]
Alginate is a cytocompatible, negatively charged polysaccha-
ride that has highly tunable mechanical and biological properties.
Figure 1. Hierarchical bone organization and schematic representation of multiscale approach toward production of hierarchical scaffolds. From nano-
metric approaches to micrometric approaches to produce a hierarchical scaffold.
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Its intrinsic viscoelasticity is dependent on the frequency of its
constituent D-mannuronic acid and L-guluronic acid blocks.
Alginate is able to act as a drug delivery vessel due to its long
release profile and possesses the interesting property of
undergoing controlled in situ gelation, making it an interesting
material for bioprinted scaffolds.[22] Abouzeid et al.[23] used bio-
mimetic mineralization and alginate gelation properties to
develop a biomimetic partial cross-linked alginate/2,2,6,6-
tetramethylpiperidine-1-oxyl (TEMPO) radical oxidized cellulose
3D printed nanofibril scaffold. The mineralization with HAp and
the improved mechanical properties of this system, when com-
pared to pure scaffolds of its components, suggests that this
approach could be promising for BTE.[23]
The great versatility of chitosan makes it one of the most used
materials in tissue engineering from nanoparticles to scaffolds.
Chitosan has the particularity of having the same structure as
glycosaminoglycans, a main component of the ECM. It also
can support cell attachment, differentiation, and migration, mak-
ing it an ideal base biomaterial for scaffold fabrication.[24] The
use of chitosan to improve the biocompatibility of a system with
nonorganic materials is shown by Pistone et al.[25] By incorporat-
ing HAp and magnetite in a chitosan matrix, they developed a
hierarchical scaffold prepared by in situ precipitation for guided
bone growth. Tests showed that the HAp and magnetite were
homogeneously dispersed in the chitosan matrix. Moreover, it
was shown that the incorporation of HAp and magnetite
Table 1. Macrometric approaches used in BTE. Hap, hydroxyapatite; TEMPO, 2,2,6,6-tetramethylpiperidine-1-oxyl; PLGA, poly(lactic-co-glycolic acid);
ECM, extracellular matrix; TCP, tricalcium phosphate; 3D, three-dimensional; dECM, decellularized extracellular matrix.
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provided the composite with overall improved biocompatibility
and capacity to support osteoblastic cells’ attachment and
proliferation.[25]
The most widely used synthetic polymer in BTE is poly(lactic-
co-glycolic acid) (PLGA). It is a very versatile material with
multiple applications from the nano- and microrange. However,
despite its degradation rate being easily tuned, a desirable
property for scaffolds’ design, its weak mechanical properties,
and poor osteoconductivity limit cellular adhesion to the
scaffolds.[26] For so, Kong et al.[27] used oxidized chondroitin
sulfate (oCS) and collagen type I (oCS-Col I) coating to overcome
the PLGA scaffolds’ mechanical and osteoinductive shortcom-
ings. The coating was performed by layer-by-layer deposition
and further mineralized by nanohydroxyapatite (nHA). When
compared to pure PLGA scaffolds, this system showed
improved mechanical properties, as well as cell attachment,
spreading, and proliferation. Furthermore, the biomimetic scaf-
folds promoted osteogenic differentiation of BMSCs, as shown
by the upregulated expression levels of osteogenic markers
(Figure 3).[27]
Figure 3. PLGA scaffolds coated with oCS-Col I. a) Pure PLGA scaffolds and PLGA coated with oCS-Col I multilayers after biomineralization (HAP/
mPLGA). b) Quantification of osteogenic markers showing a visible increased expression in the HAP/mPLGA scaffolds in comparison with the pure
PLGA scaffolds. Adapted with permission.[27] Copyright 2018, Wiley Periodicals, Inc.
Figure 2. Bone structure and some of the most common approaches to
mimic its hierarchical structure. Bioceramics, natural and synthetic poly-
mers, and the dECM are the most used materials to try to recreate the
bone architecture and specific composition.
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2.2. Bioceramics
The use of bioceramics in bone scaffolds’ fabrication has gained
interest due to their strong mechanical properties and chemical
similarity to native bone tissue. These biomaterials present
biocompatibility, osteoconductivity, and a surface that absorbs
osteoinductive factors, which facilitates osteogenic differentia-
tion. The main disadvantage of ceramic materials is the high brit-
tleness that can difficult degradation control.[12] A good
example of its effect on osteogenic differentiation is shown in
the work of Xu et al.[28] They developed 3D-plotted hierarchical
β-tricalcium phosphate (TCP) scaffolds treated with dopamine-
tris/HCl (TCP-DOPA-Tris) and dopamine-simulated body fluids
solutions (SBF) (TCP-DOPA-SBF) to form apatite mineralization
inducing structures (Figure 4). The nanostructured surface of
these scaffolds improved osteogenesis as shown by bone-related
gene expression and ALP activity tests performed on BMSCs,
thus showing to be a viable tool for BTE.[28]
Bioactive glasses have the particularity to form reactive carbon-
ated HAp when immerged into biological fluid, making it able to
bond to mineralize bone tissue. Furthermore, ion release of
bioactive glasses is known to stimulate gene transcription and
expression of genes involved in osteoblast proliferation, ECM
remodeling, and other important processes for bone homeosta-
sis. The mentioned characteristics make bioactive glass an inter-
esting material for bone regeneration application and an optimal
base material for bone scaffold production.[29,30] For example,
Fernandes et al.[31] developed a fiber bonding technique and
wetspun porous poly-L-(lactic acid)-borosilicate bioactive glass
scaffold for bone regeneration. The incorporation of bioactive
glass resulted in a consistent release profile of inorganic species,
producing calcium phosphate structures on the surface material.
Additionally, in tests conducted with hASCs, the system pro-
moted cell adhesion and proliferation, thus providing nontoxic
structural support for cell growth.[31]
2.3. dECM
The natural characteristics of the ECM and its composition,
alongside the difficulty to artificially replicate its properties
Figure 4. Photos of the 3D printed TCP, TCP-DOPA-Tris, and TCP-DOPA-SBF scaffolds. a) Overview of TCP, TCP-DOPA-Tris, and TCP-DOPA-SBF scaf-
folds b) in a 45–90–135 lay-down pattern. c,f ) Visualization of macroporous and surface microstructures of TCP; d,g) TCP-DOPA-Tris; and e,h) TCP-
DOPA-SBF. Reproduced with permission.[28] Copyright 2016, The Royal Society of Chemistry.
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and complexity, make the dECM an ideal raw biomaterial for
tissue engineering, far superior to any other engineering
approach.[32] dECM can be obtained through decellularization
of tissue and also cell-derived matrix (CDM). The decellulariza-
tion process is of great importance for the further use and
application of the ECM in tissue engineering. This process pre-
vents the occurrence of immunological responses.[33] It is
practically impossible to preserve entirely the natural properties
of the ECM during decellularization. Every method will alter it in
some form; hence, the goal of this process consists in the
maximal removal of cellular material while altering as little as
possible the structure and components of the ECM.[34] In the
case of tissue-derived dECM, the harsh physical and chemical
methods applied can lead to the extraction or denaturation of
components of interest. Despite this, tissue-derived dECM
retains most of its protein content and its complex 3D architec-
ture, thus being an excellent scaffold material.[35] In the very
interesting work of Alom et al.,[36] demineralized bone matrix
(DBM) and decellularized bovine bone tissue (bECM) were used
to prepare hydrogel scaffolds for osteogenic differentiation
purposes. The bovine tissue was first demineralized in 0.5N
HCl solution for 24 h, under agitation at 300 rpm and at room
temperature. Afterward, the demineralized tissue was decellular-
ized in 0.05% trypsin and 0.02% ethylenediaminetetraacetic
acid at 37 C for 24 h. Hydrogels were then produced by
enzymatic digestion, solubilization, and neutralization. Tests
were performed with myoblasts and mouse primary calvarial
cells, which were seeded on DBM, bECM, collagen type I, and
tissue culture plastic in the presence and absence of an
osteogenic medium (Figure 5). The expression of osteogenic
markers showed a remarkable increase in expression in both
DBM and mainly bECM when cultured in basal medium
comparatively to tissue culture plastic and collagen type I.
The results suggest that both demineralized and decellularized
bone tissue are promising approaches for bioactive scaffolds
for BTE.[36]
Figure 5. Decellularized bovine bone tissue (bECM) hydrogel scaffolds. a) Schematization of produced bECM hydrogel scaffolds. b–e) Expression of
osteogenic markers in mouse primary calvarial cells seeded on bECM, DBM, collagen type I hydrogels, and tissue culture plastic cultured in basal and
osteogenic medium. bECM evidenced the highest expression when cultured in a basal medium. Adapted with permission.[36] Copyright 2017, Wiley
Periodicals, Inc.
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Besides tissue-derived dECM, cell-derived matrices also pres-
ent an interesting alternative to conventional tissue engineering
approaches. Although these matrices present a lower complexity
than tissue-derived matrices, CDM can be derived from
autologous cells, allow for easier pathogen elimination, and
can be created using patient-specific cells.[37] The use of a single
cell type as a base for a cell culture model allows for a more pre-
cise analysis of its biological potential and also facilitates a high
degree of customization. CDMs can be engineered by introduc-
ing soluble factors, proteins of interest, or coculturing different
cell types before decellularization.[38] The use of dECM for scaf-
fold fabrication, albeit its obvious advantages, is still in its early
stages. However, this interesting technology will certainly be
vastly explored in BTE, in a near future.
3. Micrometric Approaches
The recent advances in microfabrication processes have led to an
increase of microscale approaches in biomedical engineering,
like microscaffolds and microparticles-based approaches, as
shown in Figure 6.
The ability to control the micrometric pore size, morphology,
or distribution is a valuable tool for tissue engineering.[39]
Furthermore, efficient drug delivery systems and mechanical
reinforcement strategies are possible through this approach.
Table 2 summarizes the advanced fabrication techniques that
can allow for a vast range of materials to be used in BTE.[40–47]
The mimicking of the native tissue architecture and composition
at a microscopic level is of high importance for the development
of more complete and efficient tissue engineering approaches
that more closely resemble natural bone.
3.1. Microscaffolds
The development of microscaffolds for BTE applications has
gained attraction in recent years. A vast array of biomaterials
and processing methods can be used to craft these devices for
multiple applications. Gelatin, nHA, chitosan, calcium phos-
phate, or synthetic polymers like polycaprolactone (PCL) are
the most used base biomaterials for these structures in BTE
applications.[40–42,48]
Gelatin is the denatured form of collagen and has a very simi-
lar composition to it, which makes gelatin a promising biomate-
rial for bone tissue strategies as shown in the work of Yin et al.[40]
which combined gelatin and nHA to construct 3Dmicroscaffolds
within the pores of a porous titanium scaffold. Selective laser
melting was used for the fabrication of porous titanium scaffolds
and chemical cross-linking for microscaffolds production. This
hybrid scaffold was tested for cell adhesion, proliferation, and
differentiation with preosteoblasts cells. The results showed that
this system presented good biocompatibility. Moreover, it was
evidenced an increase of cell proliferation and enhanced cell
adhesion, while gene expression analysis showed upregulation
of osteogenic markers, leading to osteogenic differentiation.
Furthermore, regenerated bone volume in vivo was also
increased.[40] Showcasing the ability of chitosan, nHA, and
gelatin to stimulate constituent components of natural bone,
Wang et al.[41] tested an injectable microscaffold for the regener-
ation of subchondral bone knee lesions. These scaffolds were fab-
ricated using a microstencil array chip, cryogelation, and
lyophilization. In this study, the therapeutic potential was tested
on an induced subchondral bone lesion, using rabbits as an ani-
mal model. The injected microscaffolds displayed optimal poros-
ity, stiffness, swelling ratio, and favored cellular infiltration.[41]
A different approach using microscaffolds was followed by
Lin et al.[42] For this approach, the salt leaching and molding
method was used to create calcium phosphate cement microscaf-
folds. The work aimed to combine the bioresorbable bone sub-
stitute calcium phosphate cement with osteoinductive hrBMP-2
adsorbed onto the microscaffold to achieve a more effective
treatment for bone repair. The viability of this model was first
tested on a rabbit distal femur defect model which yielded
optimal bone regeneration 3months after microscaffold implan-
tation. In a pilot clinical trial, even compared to current clinical
therapies, the implanted microscaffolds shortened the average
fracture healing time by 0.5–2months.[42]
In the case of synthetic materials, Totaro et al.[48] exploited
PCL’s excellent processability and mechanical properties to fab-
ricate a porous PCL microscaffold functionalized with HAp
nanoparticles for in vitro modular BTE. These microscaffolds
were prepared via four-step thermally induced phase separation
and tested for their capacity to support cell adhesion, growth, and
osteogenic differentiation of human mesenchymal stem cells
(hMSCs). Gene expression analysis results showed that the
microscaffolds induced osteogenic differentiation even without
the addition of exogenous osteogenic factors (Figure 7).[48]
3.2. Microparticles
Microparticles are particles in the 1–1000 μm diameter range.[49]
They can be divided into microspheres and microcapsules
according to their morphology.[50] In BTE, the use of micropar-
ticles for drug delivery purposes has been extensively explored.
There is an ample group of biomaterials, from natural to
synthetic, that can be used for microparticles production such
as HAp, chitosan, gelatin, PGLA, or polylactide-poly(ethylene
glycol) (PELA), among others.[43–47]
Figure 6. Bone microstructure and some of the most common
approaches to mimic its hierarchical structure. Microscaffolds and micro-
particles are commonly used to imitate the microstructure or deliver bio-
active molecules.
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As an interesting model for drug release, Ren et al.[43] studied
the sequential release of BMP-2 and VEGF from PELA
microcapsule-based scaffolds for bone defect treatment. Using
the improved double emulsion/solvent evaporation technique,
VEGF and BMP-2 were encapsulated in PELA microcapsules
and fused to scaffolds using the dichloromethane vapor method.
The results showed that the microcapsule-based scaffolds
promote the differentiation of rat mesenchymal stem cells into
osteoblasts as shown by the increased ALP expression, as well as
quantification of extracellular signal-related kinase, a differentia-
tion stimulator. The sequential release of BMP-2 and VEGF
proved to be an interesting approach for the treatment of bone
defects.[43] Similarly, to develop a system that allowed a controlled
release of the growth factors and osteogenic proliferation,
Sobhani et al.[44] incorporated BMP-2-loaded chitosan micro-
spheres into polyphosphazene/calcium phosphate scaffolds.
This process occurred by using calcium phosphate porous
samples prepared through the sintering method and then
composited with poly(dimethylaminoethanol)phosphazenes.
The chitosan microspheres loaded with BMP-2 were
incorporated in the poly(dimethylaminoethanol)phosphazenes.
Moreover, they confirmed the nontoxic behavior of the scaffolds
through cell adhesion and cell viability tests with rat osteosar-
coma ROS17/2.8 cells, making this system a viable tool for
BTE.[44] In a different approach, Li et al.[47] used chitosan due
to its biocompatibility, biodegradability, and similarity to
ECM. In this study, a porous chitosan/nHA composite scaffold
was produced and improved with the osteogenic induction agent,
simvastatin that was loaded into PLGA microspheres. The sys-
tem was fabricated by combining freeze-drying techniques with
the water–oil–water emulsion method. Drug kinetics showed
that the release of the simvastatin happened in a sustained
Table 2. Micrometric approaches used in BTE. nHA, nanohydroxyapatite; 3D, three-dimensional; PCL, polycaprolactone; PELA, polylactide-poly(ethylene
glycol); PLGA, poly(lactic-co-glycolic acid).
Category Type of
material
Fabrication methods Scaffold strategies Advantages of material Disadvantages of materials References
Microscaffolds Gelatin Chemical cross-linking 3D microscaffolds
with suitable pore
size
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manner, and the PLGA microspheres presented high encapsula-
tion efficiency. Furthermore, in comparison to the chitosan/nHA
composite scaffold without simvastatin, this system presented a
better-suited microenvironment for BMSCs proliferation and
increased osteogenic marker expression. Also, in a critical-sized
calvarial defect rat model, a positive effect on bone repair was
observed.[47]
In an interesting work, Cholas et al.[45] used microspheres to
mechanically improve the scaffold system. They tried to produce
biomimetic scaffolds using HAp mesoporous microspheres,
which were prepared through spray drying precipitated HAp
and then incorporated into collagen scaffolds (Figure 8). The
porous nature of the collagen matrix allowed for the uptake of
the microspheres and created a composite scaffold with superior
compressive modulus when compared to pure collagen scaffolds.
Despite the composite scaffolds being able to support cell
growth, tests with preosteoblasts cells showed no effect on cells’
proliferation. Interestingly, the microspheres affected the cells’
morphology, as cells grown in the composite scaffold presented
a rounded morphology similar to osteocytes while cells grown in
collagen-only scaffolds presented an elongated shape.[45]
Another example showed the use of gelatin microspheres
loaded with BMP-2 and incorporated into PLGA scaffolds to
enhance osteogenesis.[46] Combining phase inversion and
particulate leaching, a PLGA scaffold was prepared onto which
water-in-oil emulsion obtained gelatin microspheres were incor-
porated via phase inversion. Tests were performed in vitro and
on a defect radius of a rabbit after X-ray radiation in vivo.
An enhancement of the mechanical properties of the PLGA scaf-
fold was verified after the incorporation of the microspheres.
Furthermore, in vitro results showed an improvement in prolif-
eration and osteogenesis.[46]
4. Nanometric Approaches
The ever-greater incorporation of nanotechnology in tissue engi-
neering approaches allowed for greater detail at the nanoscale
necessary for reaching the next step in biomimetic tissue engi-
neering (Figure 9).
In particular, the use of nanotechnology specifically tailored
for the bone nanostructure, allowing for the development of
more efficient drug delivery or mechanical reinforcement tools
optimal for the bone tissue environment.[51] Table 3 summarizes
the several nanometric approaches comprising nanoparticles,
nanocomposites, and nanosheets that can be used combined
with top-down tissue engineering systems to more closely mimic
the bone natural composition and its ECM.[52–71]
4.1. Nanoparticles
Nanoparticles are a valuable tool in BTE due to their versatile
nature. Nanoparticles have shown promising results in promot-
ing osteogenesis and osteointegration of other materials.[72,73]
The major applications for nanoparticles in BTE are as vessels
for delivering bioactive molecules and cell labeling. They are also
commonly used in conjunction with scaffolds to enhance osteo-
conductive, osteoinductive, and mechanical properties for bone
regeneration.[74] Nanoparticles used for BTE can be classified as
degradable or nondegradable, according to their composing base
material.[75] The selection of the base material highly depends on
the desired end application of the nanoparticles.
4.1.1. Degradable Nanoparticles
Degradable nanoparticles can be prepared from various
materials such as natural and synthetic polymers. Degradable
nanoparticles are biodegradable and biocompatible, thus making
Figure 7. PCL microscaffolds with HAp nanoparticles for in vitro modular
BTE. a) hMSCs proliferation on nanocomposite microscaffolds over the
culture time, as measured by Alamar blue assay. A significant difference
(p< 0.05) was detected between osteogenic medium (OM) and standard
culture medium (SM) at 21 and 28 days. b–e) H&E staining after 28 days
for both SM and OM showed complete integration of the cells by their
ECM (white * indicates microscaffold and black * indicates de novo
ECM). f ) SEM image evidencing PCL structure; g) SEM image evidencing
PCL-HA structure. Reproduced with permission.[48] Copyright 2015, John
Wiley & Sons, Ltd.
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them an interesting tool for drug delivery and scaffold assembly.
In fact, they can be combined with bioactive components, which,
when associated with hierarchical scaffolds, can more closely
mimic the natural composition of the bone.[75] For example,
bovine serum albumin (BSA) is a protein that has shown prom-
ising results in prolonging drug release due to its high half-life.
The combination of high half-life with ease of administration and
stability makes it an optimal drug carrier.[76] With this in mind,
Xie et al.[53] developed BSA and silver nanoparticles (AgNPs) to
be used as a delivery vessel for BMP-2. Nanoparticles were
adsorbed to calcium phosphate mineralized graphene oxide/
chitosan scaffolds with hierarchical structures. These scaffolds
were fabricated by immersion of graphene oxide/chitosan
scaffolds in supersaturated calcium and phosphate solution to
achieve biomineralization. Furthermore, the scaffolds were
immersed in the nanoparticle solution for adsorption. The BSA
nanoparticles were produced using the desolvation method and
stabilized with chitosan through electrostatic interaction. AgNPs
were synthesized by reduction of silver nitrate. With this
approach, they were able to not only enhance the osteoinductivity
of the scaffolds but also enhance their antibacterial properties. In
a different example, Han et al.[59] investigated chitosan-coated
BSA nanoparticles and oxidized alginate deposited in a layer-
by-layer manner on porous titanium scaffolds (Figure 10).
Through sequential assembling of chitosan-coated BSA nanopar-
ticles and negatively charged oxide alginate on the titanium
scaffolds, BMP2 dropped and absorbed on the layer-by-layer film.
The chitosan-coated BSA nanoparticles were synthesized via
desolvation.
Using this strategy, they were able to produce nanostructured
scaffolds with improved surface biocompatibility, functionality,
and loaded with growth factors and antibacterial agents. This
modification enhanced ectopic bone formation in vivo, improved
cell adhesion, cell proliferation, and induced osteogenic differen-
tiation of bone marrow stromal cells in vitro as confirmed by ALP
activity assay.[59]
Another material with good biocompatibility is SF, a hydro-
phobic structural protein composed of an equimolar ratio of a
heavy hydrophobic chain and a light relatively hydrophilic chain
of protein, most commonly obtained from Bombyx mori.[77,78]
The ability to use several processing techniques to obtain a vast
array of morphologies and scaffold types, from nanoparticles to
hydrogels, is another great advantage of SF.[19] More specifically,
the SF structure similarity to the native structure of collagen type
I combined with its excellent mechanical properties, slow degra-
dation rate, and high morphology control makes it an extremely
Figure 8. SEM images of collagen scaffolds. Comparison between a,b) pure collagen scaffolds and c,d) collagen/HAp mesoporous microspheres scaf-
folds. Scale bars: a,c) 100 μm, b,d) 20 μm. Reproduced with permission.[45] Copyright 2016. Elsevier B.V.
Figure 9. Bone nanostructure and some of the most common approaches
at nanoscale to incorporate hierarchical elements. Nanoparticles, nano-
composites, and nanosheets are among the most studied approaches
for delivery of biological active molecules or structural reinforcement.
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Table 3. Nanometric approaches used in BTE. BSA, bovine serum albumin; PLGA, poly(lactic-co-glycolic acid); Hap, hydroxyapatite; ECM, extracellular
matrix; PLLA, poly (L-lactic acid).
Category Type of material Fabrication method Scaffold strategies Advantages Disadvantages References













Silica Sol–gel synthesis Deposition on scaffold
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drying
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versatile material for BTE applications.[77] Huang et al.[52] took
advantage of the negative charge repulsion caused by the silk
shell to prevent nanoparticle aggregation. In this work, aqueous
precipitation reaction synthesized HAp/SF core–shell nanopar-
ticles were combined with ECM mimetic porous SF scaffolds
produced through freeze-drying. This resulted in scaffolds with
homogenous nanoparticle distribution, higher HAp content by
40%, higher ALP activity, and higher calcium deposition, achiev-
ing better growth and osteogenic differentiation.[52]
In the special case of synthetic polymers, such as PLGA, they
have not only the advantage of being cost-effective, easy to pro-
duce, and biocompatible, but also that the degradation profile can
easily be tuned to achieve optimal release profiles. Even through
PLGA hydrolytic degradation, which produces acidic products,
can be a problem.[79] Evidencing the mentioned degradation
properties, Zhou et al.[54] used PLGA nanoparticles to encapsu-
late transforming growth factor-beta (TGF-β1). The goal of this
study was to develop a 3D printed scaffold with a hierarchical
structure for osteochondral regeneration. The PLGA nanopar-
ticles with encapsulated TGF-β1 were produced via the coaxial
electrospraying method. Then, using 3D printing technology,
gelatin methacrylate (GelMA) and polyethylene (glycol) diacrylate
(PEGDA) were used as primary ink in a layer-by-layer manner
deposition using a stereolithography-based 3D printer. By using
PLGA nanoparticles, the release of the growth factors was
modulated onto BMSCs, emulating the bone composition.
This interesting scaffold design successfully upregulated the
expression of osteogenesis-associated genes. The results evi-
denced the osteogenic differentiation potential of this system,
which was further confirmed by histological staining of calcium
deposits with Alizarin red.[54]
4.1.2. Nondegradable Nanoparticles
Nondegradable nanoparticles are usually composed of a wide
range of materials like ceramics, metals, among others, that
can be used to produce several constructs in a wide spectrum
of sizes and shapes.[75] These nanoparticles, although mostly
displaying some levels of toxicity, can make use of the inherent
properties of their raw material allowing them, for example, to
create magnetic fields that can allow envisioning the use of
magnetic nanoparticles.[80,81] Nondegradable nanoparticles have
a vast variety of applications such as drug delivery, imaging, and
reinforcement of the mechanical structure of scaffolds.[82]
One example of widely used nondegradable metal nanopar-
ticles in BTE is the gold nanoparticles (AuNPs). AuNPs possess
good biocompatibility, low toxicity, and tunable stability, making
them a versatile tool for drug delivery, imaging, and diagnosis
among other applications.[83] Moreover, AuNPs have been shown
Table 3. Continued.
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to promote osteogenic differentiation[84] as shown by Lee et al.[61]
They took advantage of the AuNPs osteoinductivity to develop a
3D printed PCL scaffold coated with AuNPs grown on a
polydopamine coating. PCL scaffold was produced using a rapid
prototyping 3D printing system and evenly coated with polydop-
amine. The coating acts as a reductant of gold ions forming
AuNPs. The use of polydopamine coating led to an increase
in AuNPs’ growth on the scaffolds in comparison with standard
PCL scaffolds. The combination of a higher nanoparticle growth
due to the polydopamine coating led to great results in osteogenic
activity as shown by the increase in ALP activity, exhibiting excel-
lent new bone formation in in vivo tests.[61] Another example is
the silver nanoparticles (AgNPs). The antibacterial properties of
Ag make it very appealing for tissue engineering approaches.[85]
For example, these properties were used by Correia et al.[57] to
develop 3D printed TCP/sodium alginate scaffolds with bacteri-
cidal activity. TCP/sodium alginate scaffolds were produced by
rapid prototyping 3D printing and functionalized with AgNPs
by adsorption and direct incorporation into the composite
mixture. The direct incorporation of AgNPs produced a system
suitable for BTE with biocompatibility, and appropriate mechan-
ical properties. Both functionalization methods showed great
antibacterial activity.[57] Other metals like titanium and platinum,
although rarer, are also used in BTE for nanoparticle synthesis.
These materials allow for controlled sized range, functionaliza-
tion, topography, and use as contrast agents.[86] Platinum has
been shown to exhibit an optimal catalytic ability and anti-inflam-
matory ability. This is due to its capacity to impair the down-
stream pathways leading to inflammation,[87] while titanium
implants with rough topography and free energy increased cell
adhesion and subsequent bone formation.[88] In the very interest-
ing work of Radwan-Praglowska et al.,[63] three different metal
nanoparticles were used (platinum, gold, and titanium dioxide
(TiO2)) to dope 3D hierarchical, nanostructured chitosan/poly-
lactic acid (PLA)/HAp scaffolds for guided BTE. These scaffolds
were prepared by placing a nanofibrous 3D PLA mat onto a chi-
tosan aerogel followed by lyophilization and embedding of Au,
TiO2, or platinum nanoparticles at 1%. In fact, the conductivity
characteristic of the nanoparticles enabled the stimulation of cell
proliferation by inducing an electric current. Moreover, they
exhibited antibacterial activity, which improved the mechanical
properties of the scaffolds. In this study, comparing the three
nanoparticles tested, the TiO2 nanoparticles samples displayed
the highest bioactivity in contact with cells. It was also verified
Figure 10. Chitosan-BSA nanoparticles loaded–oxidized alginate titanium scaffolds. a) Schematics of chitosan-coated BSA nanoparticles and oxidized
alginate deposited in a layer-by-layer manner on porous titanium scaffolds for bone regeneration and anti-infection as an example of nanoparticles used
to improve bone regenerative scaffold systems. b) Titanium scaffolds before modification. Adapted with permission.[59] Copyright 2017, Wiley
Periodicals, Inc.
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that scaffolds containing AuNPs showed the highest increase in
biomineralization.[63]
The use of magnetic nanoparticles in BTE is also a promising
approach. In fact, it is known that magnetic fields can improve
the integration of implants and the mineral density of newly
formed bone and promote faster defect healing.[81] These fea-
tures associated with the possibility of magnetic nanoparticles
serve as drug delivery and gene transfection vessels, which have
prompt scientists to explore them extensively in recent years.[89]
A combination of these properties was shown by Saber-
Samandari et al.[90] They used magnetic nanoparticles as
photothermal conversion agents to develop bifunctional
nanocomposite scaffolds for photothermal therapy and tissue
engineering. The entrapping of carboxyl-functionalized multi-
walled carbon nanotubes and embedding of magnetic iron oxide
nanoparticles into the porous matrix of the scaffold resulted in
the increased adsorption of BSA on the surface. Additionally,
they also observed that the presence of magnetic nanoparticles
improved the biocompatibility, as confirmed using an osteoblas-
tic cell line, and the compressive strength values of the
scaffolds.[90]
Another interesting approach is the use of carbon for nanopar-
ticle development. The unique and versatile properties of carbon
have made it an ideal candidate for the development of new BTE
strategies. Carbon can be processed in several different dimen-
sions, from 3D graphite, 2D graphene, 1D carbon nanotubes to
0D carbon dots or carbon nanodiamonds.[91] The most used
iteration of carbon nanoparticles is carbon nanotubes which
can be single-walled carbon nanotubes (SWCNTs) or multiwalled
carbon nanotubes (MWCNTs). These possess good strength,
elasticity, and fatigue resistance and can be used to improve
the overall mechanical properties of constructs. Their high affin-
ity for cell binding proteins can promote stem cell differentiation
and their electrical conductivity can be controlled by adjusting
size and diameter.[92,93] Additionally, the carbon nanotubes’
unique electrical conductivity has also gained increasing interest
in BTE. Electrical stimulation can accelerate bone formation,
regeneration, ECM protein synthesis, and enhance osteogenic
markers expression.[94] Another important advantage of carbon
nanotubes is that their micrometer length and nanometer
diameter resembles constituents of ECM of connective tissue
such as collagen fibrils.[64] With this in mind, Świętek et al.[64]
used hydroxylated MWCNTs in combination with magnetic iron
oxide nanoparticles incorporated into a porous PCL matrix to
create a multifunctional system that enables multiway cell stim-
ulation. These hybrid nanoparticles were synthesized by copre-
cipitation, and the solvent casting/porogen leaching method was
used to fabricate the scaffolds. This preliminary research devel-
oped with an osteoblastic cell line showed that the carbon nano-
tubes had a positive effect on cell adhesion.[64]
Bioceramics are also commonly used in BTE, silica, HAp,
calcium phosphate, and bioglasses are some of the most used
bioceramics. On one hand, silica nanoparticles have shown to
be very interesting for tissue engineering due to their excellent
bioactivity, low toxicity, and bone tissue development properties
when in contact with physiological fluids[95] as shown by
Qiu et al.[55] In this study, they used aminated mesoporous silica
nanoparticles (MSNs-NH2) as drug delivery vessels for
dexamethasone onto poly (L-lactic acid) (PLLA)/PCL composite
scaffolds for BTE. PLLA/PCL composite scaffolds were fabricated
via thermally induced phase separation on which drug-loaded sil-
ica nanoparticles were placed with electrophoretic deposition.
These nanoparticles were produced using sol–gel synthesis.
The results obtained on BMSCs showed a sustained release of
dexamethasone and higher ALP activity and collagen content after
21 days when compared to scaffolds without dexamethasone-
loaded silica nanoparticles (Figure 11).[55]
On the other hand, HAp is an abundant element in the natural
composition of bone tissue, reinforcing the organic part of the
bones’ hierarchical structure.[96] For so, to better mimic bone
tissue, Guillaume et al.[62] used HAp nanoparticles to dope
composite polymer scaffolds to promote bone repair. Photo-
cross-linkable poly(trimethylene carbonate) (PTMC) was
prepared with different contents of HAp nanoparticles; these
were obtained using the wet precipitation method. For composite
scaffolds fabrication stereolithography was used, obtaining
Figure 11. Dexamethasone-loaded MSNs-NH2 PLAA/PCL scaffolds for BTE applications. a) Schematic representation of dexamethasone-loaded MSNs-
NH2 PLAA/PCL scaffolds (DEX@MSNs-NH2 PLAA/PCL) illustrating the different interactions between the MSNs-NH2, dexamethasone, and the scaf-
fold. b) In vitro ALP activity, and c) collagen content of BMSCs cultured on the tested scaffolds showed evident differences between DEX@MSNs-NH2
PLAA/PCL and scaffolds without dexamethasone (PLLA/PCL and MSNs-NH2 PLAA/PCL), demonstrating the drug delivery capacity of MSNs-NH2.
Adapted with permission.[55] Copyright 2016, American Chemical Society.
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PTMC/HAp scaffolds. The surface-enrichment with HAp
allowed a microscale distribution at the surface of the structures,
and bone formation was obtained even at low concentrations of
HAp.[62] In fact, calcium phosphates are osteoconductive,
osteoinductive, and have the ability to be resorbed by the cells
making them a great tool for drug delivery,[97] as shown in
the very interesting work of Chen et al.[98] They developed
composite scaffolds of collagen and dexamethasone-loaded
biphasic calcium phosphate nanoparticles to achieve a sustain-
able release of dexamethasone, calcium, and phosphorous ions.
The nanoparticles were produced using the coprecipitation
method, loaded with dexamethasone, and hybridized with colla-
gen. The dexamethasone-loaded scaffolds were fabricated using
preprepared ice crystals as porogen material. The obtained nano-
particle/collagen/ice solution was poured into silicon frames
placed on copper plates, and then the frames were frozen and
freeze-dried. The homogeneous distribution of nanoparticles
enhanced the mechanical properties as well as the roughness
of the scaffolds. Tests performed with hMSCs showed that the
system displayed good biocompatibility and promoted osteogenic
differentiation. In fact, an increase in ALP activity and osteogenic
gene expression, as well as new bone tissue regeneration were
also evidenced.[98]
Bioglass has emerged as an interesting ceramic tool to be used
for hierarchical scaffold production. Furthermore, nanobioglass
has shown potential for osteogenic differentiation; because it is a
calcium-silicate-based ceramic it is able to initiate the formation
of carbonated HAp that mimics the natural bones ECM[99]
Exploring this potential, El-Fiqi et al.[60] developed a biomimetic
silanized mesoporous nanobioglass/collagen scaffold. This sys-
tem was biomimetically mineralized to enable the growth of
nHA crystals and hence more closely resemble natural minerali-
zation. The nHA/collagen porous scaffolds were prepared
through biomimetic mineralization of mesoporous nanobio-
glass/collagen hybrid porous scaffolds. Facile one-pot ultrasound
sol–gel synthesis was used for nanobioglass synthesis. These
scaffolds exhibited excellent in vivo osteogenic potential in tests
conducted in rat calvarial bone defects compared to nonminer-
alized scaffolds. The improvement of physicochemical and
mechanical properties was also verified as mineralized scaffolds
presented higher density and stiffness.[60]
Finally, one of the most used drug-delivering tools is
dendrimers; these nanoparticles possess optimal physical and
chemical properties that make them suitable for drug delivery
tools. They possess low cytotoxicity, high biocompatibility, and
their surface charge can be manipulated to interact with targeted
biosystems. Dendrimers have a well-defined nanosized structure
that allows them to cross cell membranes without premature
elimination from the body and can be internalized by several cell
types making it a very appealing strategy.[100,101] For example,
Oliveira et al.[56] used dendrimers’ drug carrier capacity to fabri-
cate dexamethasone-loaded carboxymethyl chitosan/poly(amido-
amine) dendrimer nanoparticles. These dendrimers with a 3D
system of both HAp scaffolds and starch–PCL were studied
for osteogenic differentiation on rat bone marrow stromal cells.
In brief, carboxymethyl chitosan and poly(amidoamine) den-
drimers were mixed with dexamethasone in an aqueous solution,
precipitated, submitted to dialysis, and freeze-dried. Afterward,
the resulting dendrimers were cultured onto the macroporous
scaffolds. Although quite similar, the results showed an increase
in osteoblast differentiation and enhancement of osteogenesis in
the HAp scaffolds system when compared to starch–PCL scaf-
folds. An increase in ALP activity and mineralization of the
ECM was also verified. The observed osteogenic differentiation
showed that these dendrimers may be used as suitable intracel-
lular nanocarriers for bioactive factors.[56]
4.2. Nanocomposites
Nanocomposite biomaterials are a recent class of materials that
can be defined as multiphase solid material in which one of the
phases has one, two, or three dimensions less than 100 nm.[102]
There are different types of nanocomposites: organic–inorganic,
inorganic–inorganic, and bioinorganic nanocomposites, classi-
fied according to their composition.[102] Nanocomposites can
be engineered to mimic the hierarchical nanostructure of native
tissue. They are a versatile tool with multiple applications such as
drug delivery, cancer therapy, imaging, clinical sensing, and
mechanical reinforcement.[102,103] More specifically, studies have
demonstrated nanocomposite capacity to promote cell adhesion,
cell proliferation, and osteogenic differentiation, making them
an interesting tool for BTE.[104,105] Exemplifying the tissue engi-
neering potential of such a tool, Norouz et al.[65] developed a new
nanocomposite scaffold composed of polyurethane and surface-
modified clay nanoplates for osteogenic differentiation. First,
clay nanoplates were surface modified with phosphoric acid
and calcium hydroxide, and then the clay nanoplates were com-
bined with polyurethane by a solvent evaporation–dissolution
technique forming the nanocomposites. ALP activity assay and
gene expression analysis showed a significant enhancement of
human adipose-derived mesenchymal stem cells (hADSCs)
proliferation and osteogenic differentiation. Results of this
study suggest that surface-modified clay nanoplates mediate
osteoinductive and osteoconductive responses of hADSCs.[65]
Envisioning the improvement of scaffolds’ mechanical proper-
ties, Sun et al.[66] developed a novel nanocomposite comprising
ultralong HAp nanowires decorated with zinc-containing nano-
particles to mechanically reinforce and promote osteogenesis.
Nanoparticles were produced using the one-step solvothermal
method and the nanocomposite was incorporated into a chitosan
matrix produced through freeze-drying. In tests performed with
rat BMSCs, osteogenic markers expression analysis revealed
enhanced osteogenic differentiation. Micro-CT analysis showed
that the developed nanocomposite favored in vivo bone regener-
ation when compared to pure porous chitosan scaffolds.[66] With
the same goal in mind, Abbasian et al.[67] introduced a biomi-
metic 3D scaffold with a hierarchical microstructure achieved
by combining nylon 6, baghdadite nanopowder (Figure 12),
and a sacrificial cuttlefish bone template. The scaffolds were fab-
ricated using impregnation of the N6-baghdadite solution onto a
sacrificial cuttlefish bone template in vacuum. The use of the
baghdadite nanopowder showed an improvement in the overall
mechanical properties and bioactivity of the system.
Tests using an osteoblastic cell line showed that nanocompo-
site scaffolds promoted cell attachment, spreading, and prolifer-
ation.[67] In the case of the work of Vedhanayagam et al.,[68] they
developed a method to mechanically reinforce collagen scaffolds
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without affecting their conformation or biocompatibility.
Poly(methyl) methacrylate grafted collagen scaffolds were rein-
forced with palladium oxide–titanium dioxide nanocomposites
that were produced using the sol–gel method. When compared
to pure collagen scaffolds, the nanocomposite enhanced scaf-
folds showed higher thermal stability, mechanical strength,
and enhanced osteogenic differentiation of an osteogenic cell
line. These results were confirmed by ALP activity assay and
Alizarin Red staining of calcium deposits.[68]
4.3. Nanosheets
Another recent nanometric approach studied in BTE is the use of
nanosheets. These 2D materials have gained great interest in
recent years due to their ability to alter surface properties and
thus improve the biocompatibility and cell affinity of scaffolds.[69]
Nanosheets can be used in combination can be used in combi-
nation with other biomaterials or as standalone approaches to
enhance the mechanical properties of bone scaffolds but also
for drug delivery. The most used materials for nanosheets
application in bone scaffolds are graphene oxide, synthetic poly-
mers like PLLA or PCL, and black phosphorous.[69–71]
One example of using PLLA nanosheets is described at
Murahashi et al.[70] A sustainable release drug carrier was devel-
oped using multilayered PLLA nanosheets loaded with fibroblast
growth factor-2 (rhFGF-2) for bone regeneration, as schemati-
cally described in Figure 13. Nanosheets were fabricated using
spin coating and peeling techniques. In performed tests on
critical-sized mouse femoral defects, the multilayered nano-
sheets inducedmore efficient bone regeneration when compared
to rhFGF-2-loaded gelatin hydrogels. Even after 4 weeks, trilayer
nanosheets continued to show growth factor release, along with
osteoblast differentiation associated with fibroblast growth recep-
tor 1 activation.[70]
Considering the graphite oxide nanosheets, their unique
structure and physicochemical properties prompted extensive
research for biomedical applications. In fact, its high surface
area, biocompatibility, biodegradability, and rich oxygen-
containing functional groups make them an ideal material for
scaffold fabrication.[106] Taking advantage of graphene oxide’s
physicochemical properties, Han et al.[71] used graphene oxide
Figure 12. Nylon 6-Baghdadite nanocomposite scaffold. a) Biomimetic nylon 6-Baghdadite nanocomposite scaffold and its microstructure. b) SEM and
c) TEM images of baghdadite nanopowder. Adapted with permission.[67] Copyright 2019, Elsevier B.V.
Figure 13. Multilayered PLLA nanosheets. a) Schematic representation of the process for production of multilayered PLLA nanosheets loaded with
rhFGF-2. b) Completely assembled system. Adapted with permission.[70] Copyright 2018, Acta Materialia Inc. Published by Elsevier Ltd.
www.advancedsciencenews.com www.advnanobiomedres.com
Adv. NanoBiomed Res. 2021, 2100116 2100116 (16 of 20) © 2021 The Authors. Advanced NanoBiomed Research published by Wiley-VCH GmbH
nanosheets to functionalize inert titanium scaffolds, making
them chemically active. Additionally, BMP-2 and antibiotic
(vancomycin)-loaded gelatin microspheres were immobilized
in the graphene oxide nanosheets by electrostatic interaction
providing an effective drug delivery system. Graphene oxide/
titanium scaffolds were produced using an immersing method
under vacuum filtration and gelatin microspheres were then
immobilized on the surface of the scaffold. The results of the
ALP activity of BMSCs along with in vivo ectopic bone regenera-
tion showed that this system was efficient in inducing osteogenic
differentiation and bone regeneration.[71]
Finally, in the case of black phosphorous, it has been shown
that this allotrope of phosphorous exhibits fantastic properties
for biomedicine such as excellent optical and mechanical prop-
erties, electrical conductivity, good biocompatibility, and good
biodegradation.[107] Furthermore, the degradation product of
black phosphorous is phosphate anions, a component of bone
tissue and osteoblast differentiation facilitator.[108] This makes
black phosphorous an ideal nanomaterial for BTE, as shown
in the interesting work of Liu et al.[69] They used black phospho-
rous nanosheets and graphene oxide nanosheets for surface coat-
ing of 3D stereolitography printed scaffolds with the goal to
enhance cell proliferation and osteogenesis. The graphene oxide
nanosheets’ high surface area enabled high protein adsorption
and cell adhesion on the scaffolds. Tests performed on preosteo-
blast cells showed the development of cellular filaments around
black phosphorous nanosheets, elongated cell shape, and the
release of calcium phosphate with the slight enhancement of
biomineralization. Furthermore, biomineralization and cellular
osteogenic markers values suggest that the combined use of
black phosphorous and graphene oxide nanosheets was more
efficient in stimulating cell proliferation and osteogenesis than
the nanosheets individually.[69]
5. Conclusion and Future Directions
The development of biomimetic scaffolds that more closely
resemble natural bone tissue remains a challenge. In order to
create an ideal template for bone regeneration, the mimicking
of bone tissue and ECM in both its nano- and macroenvironment
is key. This presents an especially difficult task due to the
complexity of the bone environment. Evermore precise fabrica-
tion of proper structure, organization, and bioactive constitution
in scaffolds is needed to explore the full potential of BTE as a
viable alternative to autografts. Novel processing and fabrication
technologies are being used and studied to further the advances
in the field. The incorporation and combination of biomaterials
that are able to structurally mimic the native tissue and its nano/
microscale chemical and physical properties is a step forward to
develop better hierarchical scaffolds and a step closer to provide
better clinical solutions. 3D printing technology seems to be at
the forefront of fabrication strategies that allow a wide and pre-
cise control over the properties of the construct, and its use for
BTE purposes is a growing trend. The recent nature of this tech-
nology could suggest that progress in the 3D printing area could
improve scaffold production for tissue engineering. From the
analysis of the literature, it is clear that scaffolds must have
an optimal architecture for bone growth, inherit osteogenic
and functional properties (e.g., osteoinductivity and biocompati-
bility), optimal mechanical properties, and produce or be a vessel
for bioactive factors. Although most materials fall short to pos-
sess all of these characteristics, a wide range of biomaterials are
currently known and well studied for bone scaffold fabrication
that presents interesting properties and biocompatibility
especially when combined with materials that complement or
improve the scaffold system. These materials possess multiple
applications as bioactive factors delivery vessels, enhancement
elements of mechanical and biological properties, or ideal
structures to serve as base materials for biomimetic scaffolds.
An overview of biomaterials used for the fabrication and
enhancement of hierarchical scaffolds for bone tissue applica-
tions has been presented here. The several materials that have
been proposed have shown great promise for BTE intending
to further improve the complexity of hierarchical scaffolds.
The combination of different biomaterials, fabrication proce-
dures, and engineering structures in different dimensions are
promising approaches that require further study. Fully patient-
specific approaches could mean a huge step forward in regener-
ative medicine and CDMs are a very promising material to
achieve this. The use of decellularized ECM would provide the
optimal bioactive factors and architecture needed for efficient
and functional biomimetic scaffolds. Noticeably, the vast
majority of articles analyzed for this review merely focused on
fabrication and short-term results for bone regeneration, so a
translation of these potential applications to clinical testing to
evaluate long-term results is needed. In brief, the complex struc-
ture of bone tissue requires a multidimensional approach that
takes into account multiple structural and biological factors.
Hence, to more closely mimic the natural tissue and provide bet-
ter solutions for bone lesions, an increase control in complexity
and effectiveness of scaffolds is necessary.
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